Editorial Commentary
Future direction of systemic therapy for advanced renal cell carcinoma: lessons from final and extended follow-up data from the CheckMate 9ER trial
Translational Andrology and Urology
2026;
15
(5)
:143
.
(30 May 2026)
Prime, trap, and fail: engineering chromatin to potentiate topoisomerase II poisons in prostate cancer
Translational Andrology and Urology
2026;
15
(5)
:144
.
(30 May 2026)
Diagnostic potential of urinary PENK methylation for bladder cancer in patients with hematuria: insights from a prospective and multi-institutional study
Translational Andrology and Urology
2026;
15
(5)
:145
.
(30 May 2026)
Patient experience and procedural safety in prostate biopsy: interpreting patient-reported outcome measures in the era of transperineal biopsy
Translational Andrology and Urology
2026;
15
(5)
:146
.
(30 May 2026)
When the kidney is at risk: anaesthetic technique as one piece of a larger puzzle
Translational Andrology and Urology
2026;
15
(5)
:147
.
(30 May 2026)
From trial results to bedside decisions: a time-resolved view of CheckMate-9ER
Translational Andrology and Urology
2026;
15
(5)
:148
.
(30 May 2026)
Original Article
Holmium laser enucleation of the prostate improves the renal insufficiency of benign prostatic hyperplasia with hydronephrosis
Translational Andrology and Urology
2026;
15
(5)
:149
.
(30 May 2026)
A novel metal-free sling approach for benign prostatic hyperplasia: early results of the Progator procedure with high ejaculatory preservation
Translational Andrology and Urology
2026;
15
(5)
:150
.
(30 May 2026)
In vivo proton magnetic resonance spectroscopy of the human kidney and kidney lesions: new protocol
Translational Andrology and Urology
2026;
15
(5)
:151
.
(30 May 2026)
Retrospective cohort study of intracytoplasmic sperm injection outcomes using testicular vs. ejaculated sperm among patients with non-obstructive azoospermia or cryptozoospermia
Translational Andrology and Urology
2026;
15
(5)
:152
.
(30 May 2026)
Site-specific heterogeneity in treatment response among patients with metastatic bladder cancer: implications for oligometastatic disease—a retrospective cohort study
Translational Andrology and Urology
2026;
15
(5)
:153
.
(30 May 2026)
Trends of surgical interventions for nephrolithiasis over the past decade: a population-based analysis
Translational Andrology and Urology
2026;
15
(5)
:154
.
(30 May 2026)
Long-term outcome of male urethral hemangioma: a two-center study
Translational Andrology and Urology
2026;
15
(5)
:155
.
(30 May 2026)
Association between skeletal muscle index and kidney stones in health screening populations: a single-center cross-sectional study
Translational Andrology and Urology
2026;
15
(5)
:156
.
(30 May 2026)
Differential expression of ALOX15 and GPX4 in the testicular tissue of men with obstructive and non-obstructive azoospermia: a cross-sectional study
Translational Andrology and Urology
2026;
15
(5)
:157
.
(30 May 2026)
Comprehensive bioinformatics and experimental analysis of PPOX reveals its carcinogenic effect in clear cell renal cell carcinoma
Translational Andrology and Urology
2026;
15
(5)
:158
.
(30 May 2026)
Utilizing intraoperative frozen section examination (IFSE) for diagnosis and treatment in a high-clinical-suspicion prostate cancer (PCa) cohort based on 18F-PSMA PET/CT and MRI: a pilot study
Translational Andrology and Urology
2026;
15
(5)
:159
.
(30 May 2026)
Vasectomy in Israel: motivations, satisfaction, regret, and healthcare counseling
Translational Andrology and Urology
2026;
15
(5)
:160
.
(30 May 2026)
Pulsed Thulium:YAG laser enucleation versus open simple prostatectomy for large-gland benign prostatic hyperplasia: a retrospective comparative observational study
Translational Andrology and Urology
2026;
15
(5)
:161
.
(30 May 2026)
miR-1251-5p inhibits tumorigenesis and metastasis in renal cell carcinoma by targeting MTHFD2
Translational Andrology and Urology
2026;
15
(5)
:162
.
(30 May 2026)
Bioinformatics analysis and clinical validation identify FBXW9 as a biomarker in bladder urothelial carcinoma
Translational Andrology and Urology
2026;
15
(5)
:163
.
(30 May 2026)
Curcumin improves bladder dysfunction in diabetic rats by attenuating oxidative stress via the Keap1/NRF2/HO-1 pathway
Translational Andrology and Urology
2026;
15
(5)
:164
.
(30 May 2026)
Correlation between reproductive hormone levels and genetic abnormalities in patients with non-obstructive azoospermia and oligospermia
Translational Andrology and Urology
2026;
15
(5)
:165
.
(30 May 2026)
Electrolyte trajectory-based subphenotypes and their association with hospital length of stay in prostate cancer patients
Translational Andrology and Urology
2026;
15
(5)
:166
.
(30 May 2026)
Association between prognostic nutritional index (PNI)/Controlling Nutritional Status (CONUT) score and prognosis in patients with bladder cancer: a systematic review and meta-analysis
Translational Andrology and Urology
2026;
15
(5)
:167
.
(30 May 2026)
Long-term pregnancy outcomes after deferential vessel‑sparing microsurgical vasoepididymostomy
Translational Andrology and Urology
2026;
15
(5)
:168
.
(30 May 2026)
Advancing urological practice: the value of combined antegrade and retrograde ureterography for the management of complex ureteral strictures
Translational Andrology and Urology
2026;
15
(5)
:169
.
(30 May 2026)
Recurrence and timing of conversion to radical nephroureterectomy after endoscopic laser ablation for upper tract urothelial carcinoma: a multicenter Japanese study
Translational Andrology and Urology
2026;
15
(5)
:170
.
(30 May 2026)
Analysis of factors affecting the upstaging and downstaging of renal cell carcinoma from T1 to T3a and the impact of different surgical approaches on patient prognosis and survival: a multicenter retrospective study
Translational Andrology and Urology
2026;
15
(5)
:171
.
(30 May 2026)
Super-selective bladder arterial chemotherapy for muscle invasive bladder cancer
Translational Andrology and Urology
2026;
15
(5)
:172
.
(30 May 2026)
Development and validation of a machine learning-based radiomics model using 45-keV virtual monoenergetic images for differentiating fat-poor angiomyolipoma from clear cell renal cell carcinoma
Translational Andrology and Urology
2026;
15
(5)
:173
.
(30 May 2026)
Propofol-based versus volatile anesthesia and postoperative immune response in prostate cancer
Translational Andrology and Urology
2026;
15
(5)
:174
.
(30 May 2026)
NOX4 suppresses malignant progression in prostate adenocarcinoma and functions as a potential diagnostic biomarker
Translational Andrology and Urology
2026;
15
(5)
:175
.
(30 May 2026)
N-acetylcysteine alleviates experimental autoimmune prostatitis in rats by activating PI3K/Akt/CREB and Keap1/Nrf2 pathways
Translational Andrology and Urology
2026;
15
(5)
:176
.
(30 May 2026)
The role of lipid-lowering drugs in urologic and male reproductive cancers: a Mendelian randomization study
Translational Andrology and Urology
2026;
15
(5)
:177
.
(30 May 2026)
Template-based pelvic lymph node dissection during lateral decubitus-positioned total retroperitoneal laparoscopic radical nephroureterectomy: a step-by-step description of a surgical technique
Translational Andrology and Urology
2026;
15
(5)
:178
.
(30 May 2026)
Detection of a group of classic serum tumor markers (CSTMs) aids in the differential diagnosis and disease assessment of upper tract urothelial carcinoma (UTUC)
Translational Andrology and Urology
2026;
15
(5)
:179
.
(30 May 2026)
Brief Report
Analysis of real-world re-induction outcomes with nadofaragene firadenovec in patients with Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle-invasive bladder cancer
Translational Andrology and Urology
2026;
15
(5)
:180
.
(30 May 2026)
Study Protocol
An intelligent wearable device based on electrical impedance tomography for dynamic and accurate monitoring of voiding function in patients with benign prostatic hyperplasia: protocol for a single-centre self-controlled diagnostic consistency study
Translational Andrology and Urology
2026;
15
(5)
:181
.
(30 May 2026)
Review Article
Platelet-rich plasma in selected urological conditions: a narrative review of biological rationale, current evidence, and limitations
Translational Andrology and Urology
2026;
15
(5)
:182
.
(30 May 2026)
PI‑RADS v2.1 for prostate MRI: current applications, ongoing debates, and synergies with advanced technologies—a narrative review
Translational Andrology and Urology
2026;
15
(5)
:183
.
(30 May 2026)
Garment fit, scrotal thermoregulation, and male fertility outcomes: a narrative review
Translational Andrology and Urology
2026;
15
(5)
:184
.
(30 May 2026)
Large language models for post-discharge follow-up in erectile dysfunction care: a narrative review
Translational Andrology and Urology
2026;
15
(5)
:185
.
(30 May 2026)
Bacillus Calmette-Guérin therapy in the management of upper tract urothelial carcinoma in-situ: a systematic review
Translational Andrology and Urology
2026;
15
(5)
:186
.
(30 May 2026)
Impact of bacteriospermia on sperm DNA fragmentation: a narrative review
Translational Andrology and Urology
2026;
15
(5)
:187
.
(30 May 2026)
Letter to the Editor
Rethinking survival visualisation: moving beyond Kaplan-Meier curves and hazard ratios in urology
Translational Andrology and Urology
2026;
15
(5)
:188
.
(30 May 2026)
Capivasertib plus abiraterone in PTEN-deficient metastatic hormone-sensitive prostate cancer: exploratory analysis of the proportional hazards assumption
Translational Andrology and Urology
2026;
15
(5)
:189
.
(30 May 2026)
